The Centers for Medicare & Medicaid Services (CMS) released the 2023 premiums and deductibles for the Medicare Part B programs earlier today. Medicare Part B premiums will decrease by $5.20 to $164.90 next year, and deductibles will decrease $7 to $226. AARP had called for CMS to lower Part B premiums following a decline in the price and coverage of Aduhelm, which accounted for half of the premium increase in 2022.

AARP issued a statement from Jo Ann Jenkins, AARP Chief Executive Officer, after President Biden signed the Inflation Reduction Act of 2022.

AARP issued the following statement from Jo Ann Jenkins, AARP Chief Executive Officer, following the House passage of the Inflation Reduction Act of 2022

AARP issued the following statement from Jo Ann Jenkins, AARP Chief Executive Officer, following the Senate passage of the Inflation Reduction Act of 2022

AARP issued a statement from Nancy LeaMond, AARP Executive Vice President and Chief Advocacy and Engagement Officer, on the 57th anniversary of Medicare.

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to reports that the Senate reconciliation bill will extend the solvency of the Medicare program

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today

As members of Congress return to their districts for Easter recess, AARP is kicking off a new phase of its Fair Drug Prices Now campaign and pushing lawmakers to advance the prescription drug pricing provisions, including allowing Medicare to negotiate, already passed by the House, as a top priority when they return.

Today AARP launched new television and digital advertising featuring Larry Zarzecki, a retired law enforcement officer with Parkinson’s disease who was forced to sell his home in order to afford his medications. Zarzecki first shared his story in an AARP ad three years ago, but Congress’ failure to act means he has had no relief from the high cost of his treatments. As he says in the new ad, “I shouldn’t have to decide between my home or my medicine because Congress refuses to act. I’m tired of waiting for Congress.”

AARP CEO Jo Ann Jenkins released the following statement in response to President Biden’s State of the Union speech this evening, during which he called for action on high drug prices and announced new policies to improve nursing home care